Pascrell slams China’s ‘onerous’ biotech approval requirements

Rep. Bill Pascrell (D-NJ), ranking member of the House Ways & Means trade subcommittee, last week blasted “onerous” Chinese intellectual property policies – including approval requirements for biotechnology data – as trade barriers for U.S. companies. In comments on the Office of the U.S. Trade Representative's Section 301 investigation into such practices, Pascrell said China's “restrictive requirements for the exportation (outbound) of bio-samples and sampling materials, for example, limit cross-border transport of materials and information for clinical research. Through the...